Regulated cell death in glioma: promising targets for natural small-molecule compounds
Gliomas are prevalent malignant tumors in adults, which can be categorized as either localized or diffuse gliomas. Glioblastoma is the most aggressive and deadliest form of glioma. Currently, there is no complete cure, and the median survival time is less than one year. The main mechanism of regulat...
Main Authors: | Mingyu Han, Sui Li, Huali Fan, Junsha An, Cheng Peng, Fu Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1273841/full |
Similar Items
-
Immunogenic cell death‐inducing small molecule inhibitors: Potential for immunotherapy of cancer
by: Zong Sheng Guo, et al.
Published: (2022-06-01) -
The role of costimulatory molecules in glioma biology and immune microenvironment
by: Ji Wang, et al.
Published: (2022-11-01) -
Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients
by: Wei Zhang, et al.
Published: (2024-02-01) -
Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells
by: Subashani Maniam, et al.
Published: (2021-09-01) -
Small Molecules of Marine Origin as Potential Anti-Glioma Agents
by: Ana Alves, et al.
Published: (2021-05-01)